Connor, Clark & Lunn Investment Management Ltd. - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 259 filers reported holding KARUNA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 1.0%.

Quarter-by-quarter ownership
Connor, Clark & Lunn Investment Management Ltd. ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,909,352
-2.0%
52,690
+25.7%
0.05%
+4.4%
Q2 2023$9,088,400
+25.9%
41,911
+5.5%
0.04%
+15.4%
Q1 2023$7,218,374
+3.1%
39,740
+11.5%
0.04%
-2.5%
Q4 2022$7,004,439
-21.4%
35,646
-10.0%
0.04%
-31.0%
Q3 2022$8,906,00039,5930.06%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Sofinnova Investments, Inc. 1,952,441$150,963,00011.19%
Eventide Asset Management 901,077$69,671,0001.36%
First Light Asset Management, LLC 128,200$9,912,0001.02%
Prosight Management, LP 15,826$1,224,0000.58%
MOODY ALDRICH PARTNERS LLC 30,970$2,395,0000.50%
PFM Health Sciences, LP 137,960$10,667,0000.49%
Rock Springs Capital Management LP 244,106$18,874,0000.48%
Atika Capital Management LLC 73,500$5,683,0000.46%
Hood River Capital Management LLC 132,400$10,237,0000.44%
CATALYST PRIVATE WEALTH, LLC 5,006$387,0000.38%
View complete list of KARUNA THERAPEUTICS INC shareholders